Navigation Links
Exeter scientists pour cold water on EU bird policy
Date:2/27/2008

New research from the University of Exeter in collaboration with the University of Texas at Austin published in the journal Science (22 February 2008) questions claims that EU conservation policy has been successful in protecting endangered birds.

Introduced in 1979, the EU Birds Directive set out a plan to protect rare birds in all EU countries. A study by scientists from the RSPB and BirdLife International, published in Science in August 2007, argued that the policy had resulted in positive impacts on bird conservation, even saving species that were near extinction.

This new research, however, reveals that the arguments presented in the recent study were flawed and based on inadequate data and predictions. By simply comparing bird populations inside and outside of the EU, the research did not take into account the fact that EU countries are generally wealthier and more developed than European countries outside the Union. Additionally the evidence used to support EU policy included marine reserves in some countries, but ignored them in others. The Exeter researchers argue that this created the impression that the major EU policy for bird protection has been a success when in reality it may well have fallen short of its original aims.

The new research argues that conservation policies require systematic monitoring and evaluation if they are to be scientifically valid. "Current EU conservation policy can be likened to launching a rocket to Mars, but not actually bothering to check whether it gets there" said lead author Rolando Rodrguez-Muoz of the University of Exeter. "Without properly monitoring the efficacy of its policies, the EU risks wasting millions of pounds on ineffective conservation programmes. He commented further: "The Birds and Habitats Directives have become the keystones of the EU conservation policies. They are potentially powerful tools to protect our environment, but for these efforts to be efficient we need feedback to allow us to adapt to new situations or to correct poor implementation.


'/>"/>

Contact: Sarah Hoyle
s.hoyle@exeter.ac.uk
01-392-262-062
University of Exeter
Source:Eurekalert

Related biology news :

1. Yale scientists create artificial cells that boost the immune response to cancer
2. Scientists unravel the genetic coding of the pea
3. Scientists discover giant fossil frog from hell
4. Advertisers, neuroscientists trace source of emotions in brain
5. Amazon corridors far too narrow, warn scientists
6. Dung happens and helps scientists
7. Priming scientists for successful media interviews
8. Scientists expand understanding of how river carbon impacts the Arctic Ocean
9. Fishermen and UCSB scientists explore ways to improve management of California spiny lobsters
10. Scientists rebuild ancient proteins to reveal primordial Earths temperature
11. Rice scientists make breakthrough in single-molecule sensing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology: